Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Pieris Pharmaceuticals (PIRS)

Pieris Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PIRS
DateTimeSourceHeadlineSymbolCompany
17/12/202400:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
17/12/202400:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
17/12/202400:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
17/12/202400:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
17/12/202400:42Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
16/12/202421:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
12/12/202421:15Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
12/12/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
06/12/202419:21Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
03/12/202413:30Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
03/12/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
18/11/202421:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
14/11/202414:07Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
13/11/202421:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PIRSPieris Pharmaceuticals Inc
12/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PIRSPieris Pharmaceuticals Inc
07/11/202414:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
07/11/202413:30GlobeNewswire Inc.Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic MalformationsNASDAQ:PIRSPieris Pharmaceuticals Inc
06/11/202422:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PIRSPieris Pharmaceuticals Inc
06/11/202422:00Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PIRSPieris Pharmaceuticals Inc
17/10/202412:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
17/10/202411:30GlobeNewswire Inc.Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial OfficerNASDAQ:PIRSPieris Pharmaceuticals Inc
15/10/202412:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
03/10/202412:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
03/10/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
14/08/202420:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PIRSPieris Pharmaceuticals Inc
12/08/202422:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PIRSPieris Pharmaceuticals Inc
08/08/202420:17Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PIRSPieris Pharmaceuticals Inc
08/08/202420:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
07/08/202418:16Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PIRSPieris Pharmaceuticals Inc
01/08/202412:00Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PIRSPieris Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PIRS

Your Recent History

Delayed Upgrade Clock